MD4177C1 - Method for vaccination against hepatitis B of persons with immunodeficiency - Google Patents
Method for vaccination against hepatitis B of persons with immunodeficiencyInfo
- Publication number
- MD4177C1 MD4177C1 MDA20110006A MD20110006A MD4177C1 MD 4177 C1 MD4177 C1 MD 4177C1 MD A20110006 A MDA20110006 A MD A20110006A MD 20110006 A MD20110006 A MD 20110006A MD 4177 C1 MD4177 C1 MD 4177C1
- Authority
- MD
- Moldova
- Prior art keywords
- persons
- vaccine
- immunodeficiency
- vaccination
- glucopyranosyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine and can be used in the prevention of viral hepatitis B to increase the effectiveness of vaccination.The method for vaccination consists in that simultaneously with hepatitis B vaccine is also administered an adaptogenic vegetal preparation with the active substance steroid glycoside 3-O-{[α-L-rhamnopyranosyl(1→3)]-[β-D-glucopyranosyl(1→2)]-β-D-glucopyranosyl}-[(25R)-furost-5-en,3β,22α,26-triol]-26-O-β-D-glucopyranoside (Mestim), in tablets of 50 mg, one tablet in the morning 30 minutes before a meal, within 30 days, beginning with the first day of administration of the vaccine.The result consists in intensifying the process of immunogenesis expressed in an increased titer of protective antibodies, which leads to a reduction in the risk of HBV infection to a minimum for persons with immunodeficiency and a reduction in the number of persons, non-respondent to the vaccine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20110006A MD4177C1 (en) | 2011-01-14 | 2011-01-14 | Method for vaccination against hepatitis B of persons with immunodeficiency |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20110006A MD4177C1 (en) | 2011-01-14 | 2011-01-14 | Method for vaccination against hepatitis B of persons with immunodeficiency |
Publications (2)
Publication Number | Publication Date |
---|---|
MD4177B1 MD4177B1 (en) | 2012-07-31 |
MD4177C1 true MD4177C1 (en) | 2013-02-28 |
Family
ID=46582439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20110006A MD4177C1 (en) | 2011-01-14 | 2011-01-14 | Method for vaccination against hepatitis B of persons with immunodeficiency |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4177C1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD667Z (en) * | 2013-03-20 | 2014-03-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for treatment of infectious mononucleosis in children |
MD782Z (en) * | 2013-07-16 | 2015-01-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for vaccination against influenza |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4189471A (en) * | 1978-07-11 | 1980-02-19 | Merck & Co., Inc. | Immunologic glycolipid adjuvants |
SU1162817A1 (en) * | 1983-07-06 | 1985-06-23 | Отдел Генетики Растений Ан Мсср | Method of isolating trioside of /(25r)-furost-5-en-3beta-22alpha,26 triol/-26-0-beta-d-glucopyranoside |
WO1988009336A1 (en) * | 1987-05-29 | 1988-12-01 | Cambridge Bioscience Corporation | Saponin adjuvant |
WO1993005789A1 (en) * | 1991-09-18 | 1993-04-01 | Cambridge Biotech Corporation | Saponin-antigen conjugates and the use thereof |
US5846964A (en) * | 1993-07-19 | 1998-12-08 | Tokyo Tanabe Company Limited | Hepatitis C virus proliferation inhibitor |
RU2127605C1 (en) * | 1996-05-22 | 1999-03-20 | Юрий Леонидович Криворутченко | Method of stimulation of humoral and cellular immunity response to target antigen |
MD1473G2 (en) * | 1998-06-02 | 2001-05-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Antiherpetic remedy |
WO2001097749A2 (en) * | 2000-06-23 | 2001-12-27 | Kotze, Gavin, Salomon | The use of synthetic, non-hormonal 21-aminosteroids and thereof |
MD1875G2 (en) * | 1999-11-01 | 2002-09-30 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of treatment of the acute viral hepatitis B |
MD2026G2 (en) * | 2001-12-05 | 2003-05-31 | Институт Физиологии Растений Академии Наук Республики Молдова | Process for increasing the vine crop resistance to drought |
US6905712B2 (en) * | 1999-12-08 | 2005-06-14 | Statens Veterinarmedicinska Anstalt | Vaccine adjuvants comprising ginseng plant extract and added aluminum salt |
MD3121G2 (en) * | 2005-09-15 | 2007-03-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of viral hepatitis B prophylaxis |
RU2311926C2 (en) * | 2006-02-15 | 2007-12-10 | Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" | Antigen carrier and adjuvant |
TW200808354A (en) * | 2006-08-08 | 2008-02-16 | Lotus Pharmaceutical Co Ltd | Furost-5-ene-3,22,26-triol glucoside compounds for cancer prevention and treatment |
US20100317637A1 (en) * | 2009-06-16 | 2010-12-16 | Industrial Technology Research Institute | Anti-hepatitis c composition and method for preparing drug for inhibiting hepatitis c viruses or treating hepatitis c |
JP2011001345A (en) * | 2009-06-16 | 2011-01-06 | Ind Technol Res Inst | Anti-hepatitis c composition, method for preparing agent for inhibiting hepatitis c virus or treating hepatitis c, and use of limonoid compound |
US20110218162A1 (en) * | 1998-11-24 | 2011-09-08 | Frincke James M | 15-thia steroid compounds and compositions |
UA98631C2 (en) * | 2006-12-05 | 2012-06-11 | Зентива, К.С. | Method of purification of (s)-n-methy]-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride |
-
2011
- 2011-01-14 MD MDA20110006A patent/MD4177C1/en not_active IP Right Cessation
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4189471A (en) * | 1978-07-11 | 1980-02-19 | Merck & Co., Inc. | Immunologic glycolipid adjuvants |
SU1162817A1 (en) * | 1983-07-06 | 1985-06-23 | Отдел Генетики Растений Ан Мсср | Method of isolating trioside of /(25r)-furost-5-en-3beta-22alpha,26 triol/-26-0-beta-d-glucopyranoside |
WO1988009336A1 (en) * | 1987-05-29 | 1988-12-01 | Cambridge Bioscience Corporation | Saponin adjuvant |
WO1993005789A1 (en) * | 1991-09-18 | 1993-04-01 | Cambridge Biotech Corporation | Saponin-antigen conjugates and the use thereof |
US5846964A (en) * | 1993-07-19 | 1998-12-08 | Tokyo Tanabe Company Limited | Hepatitis C virus proliferation inhibitor |
RU2127605C1 (en) * | 1996-05-22 | 1999-03-20 | Юрий Леонидович Криворутченко | Method of stimulation of humoral and cellular immunity response to target antigen |
MD1473G2 (en) * | 1998-06-02 | 2001-05-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Antiherpetic remedy |
US20110218162A1 (en) * | 1998-11-24 | 2011-09-08 | Frincke James M | 15-thia steroid compounds and compositions |
MD1875G2 (en) * | 1999-11-01 | 2002-09-30 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of treatment of the acute viral hepatitis B |
US6905712B2 (en) * | 1999-12-08 | 2005-06-14 | Statens Veterinarmedicinska Anstalt | Vaccine adjuvants comprising ginseng plant extract and added aluminum salt |
WO2001097749A2 (en) * | 2000-06-23 | 2001-12-27 | Kotze, Gavin, Salomon | The use of synthetic, non-hormonal 21-aminosteroids and thereof |
MD2026G2 (en) * | 2001-12-05 | 2003-05-31 | Институт Физиологии Растений Академии Наук Республики Молдова | Process for increasing the vine crop resistance to drought |
MD3121G2 (en) * | 2005-09-15 | 2007-03-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Method of viral hepatitis B prophylaxis |
RU2311926C2 (en) * | 2006-02-15 | 2007-12-10 | Федеральное Агентство По Образованию Государственное Образовательное Учреждение Высшего Профессионального Образования "Дальневосточный Государственный Университет" | Antigen carrier and adjuvant |
TW200808354A (en) * | 2006-08-08 | 2008-02-16 | Lotus Pharmaceutical Co Ltd | Furost-5-ene-3,22,26-triol glucoside compounds for cancer prevention and treatment |
UA98631C2 (en) * | 2006-12-05 | 2012-06-11 | Зентива, К.С. | Method of purification of (s)-n-methy]-3-(1-naphtyloxy)-3-(2-thienyl) propylamine hydrochloride |
US20100317637A1 (en) * | 2009-06-16 | 2010-12-16 | Industrial Technology Research Institute | Anti-hepatitis c composition and method for preparing drug for inhibiting hepatitis c viruses or treating hepatitis c |
JP2011001345A (en) * | 2009-06-16 | 2011-01-06 | Ind Technol Res Inst | Anti-hepatitis c composition, method for preparing agent for inhibiting hepatitis c virus or treating hepatitis c, and use of limonoid compound |
Non-Patent Citations (2)
Title |
---|
Euvax-B. Instrucţiune de utilizare a vaccinului contra hepatitei virale B, CNSP, Chişinău, 2005 * |
Types of adjuvants, Plant derivatives. Patent Landscape on Adjuvants, Patent Lens DataBase of Cambia of independent non-profit Institute, (regăsit în Internet la 2012.05.14 url: http://www.patentlens.net/daisy/adjuvants/Introduction.html ). * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD667Z (en) * | 2013-03-20 | 2014-03-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for treatment of infectious mononucleosis in children |
MD782Z (en) * | 2013-07-16 | 2015-01-31 | Национальный Центр Общественного Здоровья Министерства Здравоохранения Республики Молдова | Method for vaccination against influenza |
Also Published As
Publication number | Publication date |
---|---|
MD4177B1 (en) | 2012-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rawat et al. | COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies | |
HRP20192189T1 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
NZ606993A (en) | Combination pharmaceutical composition and methods of treating and preventing the infectious diseases | |
Zhao et al. | Eight-year survival of AIDS patients treated with Chinese herbal medicine | |
MD4177C1 (en) | Method for vaccination against hepatitis B of persons with immunodeficiency | |
Batdelger et al. | Open-label trial of therapeutic immunization with oral V-5 Immunitor (V5) vaccine in patients with chronic hepatitis C | |
MX2013003523A (en) | Low dose pharmaceutical composition comprising zanamivir. | |
Li et al. | Regulation of innate and adaptive immunity using herbal medicine: benefits for the COVID-19 vaccination | |
Kelen et al. | H1N1 vaccination in pediatric renal transplant patients | |
Jamkhande et al. | A review of approved COVID-19 vaccines | |
RU2013120345A (en) | NEW METHODS FOR TREATING INFECTIONS CAUSED BY HEPATITIS C VIRUS | |
MD3121F1 (en) | Method of viral hepatitis B prophylaxis | |
JP5846624B2 (en) | H5N1 influenza vaccine and infection protection kit | |
JP2009263384A (en) | Internal medicine for inhibiting symptom of atopic dermatitis of type i allergic disorder | |
MD596Z (en) | Method for treating chronic viral hepatitis C in children | |
AL IDRISSI et al. | Chloroquineand hydroxychloroquine in covid 19: asystematic review | |
Fried et al. | A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ORAL SILYMARIN (MILK THISTLE) FOR CHRONIC HEPATITIS C: FINAL RESULTS OF THE SYNCH MULTICENTER STUDY: 228 | |
Bhat et al. | Therapeutic Modalities in the Management of COVID-19: A Worldwide Landscape | |
JP2009263385A (en) | Internal medicine for controlling symptom of rhinitis of type i allergic disorder | |
Chaudhry et al. | A Review on the Advancements in COVID-19 Treatments and Vaccines | |
CN101244260B (en) | Combined medicament for treating chronic hepatitis B | |
Keeffe et al. | Dose-Related Increase in Virologic Responses Using Controlled Release Nitazoxanide plus Peginterferon Alfa-2a and Ribavirin for Treatment of Chronic Hepatitis C Genotype 4 | |
RU2480206C1 (en) | Method of immunocorrection of main course of treatment of destructive forms of pulmonary tuberculosis | |
CN103610935B (en) | Medicament for treating nausea and vomiting after radiography | |
MX2022006054A (en) | Dosage and administration of a bacterial saccharide glycoconjugate vaccine. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |